Nathan Starr

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Brandon Webb, Ithan D. Peltan, Paul N. Jensen et al. · The Lancet Rheumatology · 2020 · 310 citations · Full text

Life Sciences, Immunology, Infectious Diseases +7

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

Fernando Pagán, Michaeline Hebron, Barbara Wilmarth et al. · JAMA Neurology · 2019 · 187 citations · Full text

Medicine, Neurology, Pharmacology +17

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease

Fernando Pagán, Michaeline Hebron, Barbara Wilmarth et al. · Pharmacology Research & Perspectives · 2019 · 115 citations · Full text

Medicine, Neurology, Pharmacology +17

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

Samuel M. Brown, Ithan D. Peltan, Naresh Kumar et al. · Annals of the American Thoracic Society · 2020 · 40 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial

Samuel M. Brown, Ithan D. Peltan, Brandon Webb et al. · Annals of the American Thoracic Society · 2020 · 29 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14